These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4202387)

  • 1. Experience with glibenclamide.
    Rastogi GK; Dash RJ; Sinha SM
    J Indian Med Assoc; 1973 Jul; 61(1):60-2. PubMed ID: 4202387
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose, FFA, IRI and GH response to I.V. glibenclamide.
    Rastogi GK; Dash RJ; Sinha MK
    Horm Metab Res; 1973 Jul; 5(4):303. PubMed ID: 4199903
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
    Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
    Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effects of two doses of glibenclamide upon metabolic rhythms in maturity-onset diabetics.
    Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG
    Diabete Metab; 1978 Sep; 4(3):175-80. PubMed ID: 101402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of adrenergic beta-blockade using trimepranol on glucose, insulin, somatotropin and nonesterified fatty acids in the blood of women with diabetes mellitus].
    Felt V; Nedvídkrová J; Hortová O
    Vnitr Lek; 1974 Nov; 20(11):1050-4. PubMed ID: 4155166
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of blood sugar and insulin in diabetics at the suspension of glibenclamide therapy].
    Pitucco G; Caputo V; Santucci A; Daniele E; De Mattia G; De Angelis A
    Clin Ter; 1978 Jun; 85(6):550-8. PubMed ID: 97042
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of a new oral hypoglycemic product (glibenclamide-phenformin) on some aspects of lipid metabolism].
    Ceruso D; Squadrito G; Emanuele M; Quartarone M; Bellinghieri G
    Boll Soc Ital Biol Sper; 1973 Nov; 49(22):1285-9. PubMed ID: 4212680
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination].
    Beringer A
    Minerva Med; 1974 Sep; 65(60):3127-39. PubMed ID: 4214043
    [No Abstract]   [Full Text] [Related]  

  • 9. Response of immunoreactive growth hormone, immunoreactive insulin, free fatty acids and blood sugar to exercise in obese patients and in normal subjects.
    ter Haar DJ; van Riet HG; Thijssen JH; Schwarz F
    J Endocrinol; 1969 Jan; 43(1):xi-xii. PubMed ID: 5789228
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect on insulin antibodies on the effect iveness of insulin in metabolism].
    Bemm VH; Lohmann D; Thomitzek W-D ; Verlohren H-D
    Dtsch Z Verdau Stoffwechselkr; 1971; 31(2):91-6. PubMed ID: 5173538
    [No Abstract]   [Full Text] [Related]  

  • 11. [Daily curves of blood sugar and serum insulin after treatment with various combinations of glibenclamide and phenformin].
    Giangrandi E; Scaroina F; Tommasini-Degna C
    Minerva Med; 1975 Mar; 66(19):940-5. PubMed ID: 804684
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and laboratory study of the relationship between human growth hormone and the development of clinical diabetes mellitus.
    Baird JD; Hunter WM; Smith AW
    J Endocrinol; 1969 Jan; 43(1):13-4. PubMed ID: 5789217
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of serum insulin in the double intravenous glucose tolerance test in diabetics before and during glibenclamide therapy].
    Niklas L; Wiederhold K; Otto H
    Verh Dtsch Ges Inn Med; 1971; 77():546-50. PubMed ID: 5005530
    [No Abstract]   [Full Text] [Related]  

  • 14. Glibenclamide, acute/long-term response in M.O. diabetics.
    Owens DR; Wragg KG; Shetty KT; Biggs PI; Davies CD
    Horm Metab Res; 1979 Jun; 11(6):411-2. PubMed ID: 112018
    [No Abstract]   [Full Text] [Related]  

  • 15. Response of blood insulin and growth hormone to glucose infusion in normal, psoriatic and diabetic persons.
    Hopsu-Havu VK; Terho PE; Vanha-Perttula TP; Viljanen MK
    Acta Derm Venereol; 1973; 53(1):39-44. PubMed ID: 4120806
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic activity of a glibenclamide-phenformin association in maturity-onset diabetes].
    Gervasini A
    Minerva Med; 1974 Oct; 65(73):3835-42. PubMed ID: 4214284
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasmatic levels of insulin, high glucose and nefa in obese children (author's transl)].
    del Valle Núñez J; Cintado C; García Guerrero M; Ortega JL; Gayoso Gómez F
    An Esp Pediatr; 1974; 7(6):551-61. PubMed ID: 4458580
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment.
    Owens DR; Biggs PI; Shetty KJ; Wragg KG
    Diabete Metab; 1980 Sep; 6(3):219-24. PubMed ID: 6777211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of the antidiabetic action of sulfanylurea derivatives].
    Iaroshevskiĭ IuA; Volkova EA
    Klin Med (Mosk); 1982 Oct; 60(10):94-7. PubMed ID: 6757562
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth hormone releasing effects of ACTH and -MSH in man.
    Zahnd GR; Nadeau A; von Mühlendahl KE
    Isr J Med Sci; 1972 Jun; 8(6):874-5. PubMed ID: 4340669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.